We are pleased to share another collection of customer-provided Certificates of Analysis (COAs) from independent laboratory testing conducted in the United States.
These reports cover four research compounds tested by ILS Laboratories, Freedom Diagnostics, and Kovera Labs during February and July 2026.
Third-Party Laboratory Results
The submitted reports documented the following purity results:
- BPC-157 (10mg) — 99.81% Purity | ILS Laboratories
- NAD+ (1000mg) — 99.902% Purity | Freedom Diagnostics
- GLOW Blend (70mg) — 99.676% Purity | Kovera Labs
- MOTS-C (40mg) — 99.907% Purity | Freedom Diagnostics
Each report documented analytical identification and purity testing. The GLOW report also recorded negative screening results for lead, cadmium, mercury, and arsenic.
Customer-Shared Certificates of Analysis
[Insert Image 1: BPC-157 — 99.81%]
[Insert Image 2: NAD+ — 99.902%]
[Insert Image 3: GLOW Blend — 99.676%]
[Insert Image 4: MOTS-C — 99.907%]
Supporting Transparency in Research Peptides
We appreciate customers who share their independent laboratory findings and contribute to greater transparency within the research peptide community.
At GL-Peptide, we value analytical documentation, batch traceability, and open access to research-related quality information.
Research Use Only. Results apply exclusively to the individual samples tested and do not establish the quality of other batches or suitability for human use.
